Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire a 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion on July 24, 2020. As part of the transaction, Dongwha Pharm.Co.,Ltd will acquire 1,598,358 shares from Jongwook Jang, 62,000 shares from Seon-ok Kim, 16,420 shares from Min-kyung Jang, 16,420 shares from Ji-won Jang and 325,000 shares from Ho-jeong Kim in MEDYSSEY Co.,Ltd. Board of Directors of MEDYSSEY Co.,Ltd resolved the transaction and it is expected to close on September 24, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,000 KRW | -0.36% | +1.29% | +5.36% |
1st Jan change | Capi. | |
---|---|---|
+5.36% | 28.51M | |
+10.88% | 127B | |
-5.10% | 11.32B | |
+4.02% | 9.04B | |
+37.44% | 5.56B | |
-24.13% | 4.72B | |
+8.53% | 3.45B | |
-7.21% | 2.86B | |
-5.85% | 2.07B | |
-11.84% | 2.04B |
- Stock Market
- Equities
- A200580 Stock
- News MEDYSSEY Co.,Ltd
- Dongwha Pharm.Co.,Ltd agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.